A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy
2013 ◽
Vol 71
(Suppl 3)
◽
pp. 633.2-633
2015 ◽
Vol 34
(9)
◽
pp. 1513-1519
◽
2018 ◽
Vol 40
(10)
◽
pp. 1752-1764.e1
◽
1999 ◽
Vol 42
(9)
◽
pp. 1870-1878
◽
2015 ◽
Vol 35
(6)
◽
pp. 626-631
◽
2019 ◽
Vol 37
(1)
◽
pp. 41-59
◽